Welcome to LookChem.com Sign In|Join Free

CAS

  • or

59749-37-0

Post Buying Request

59749-37-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59749-37-0 Usage

Description

1-(2,6-dichlorobenzyl)-5-oxo-L-proline is a chemical compound that belongs to the family of proline derivatives. It is a white to off-white solid with a molecular formula C11H9Cl2NO3 and a molecular weight of 269.10 g/mol. This versatile chemical is often used in the synthesis of pharmaceuticals and as a building block in organic chemistry, playing a significant role in the development of various pharmaceutical and organic compounds.

Uses

Used in Pharmaceutical Synthesis:
1-(2,6-dichlorobenzyl)-5-oxo-L-proline is used as a building block for the synthesis of pharmaceuticals, particularly in the development of antiviral and antibacterial medications. Its unique structure and properties make it a valuable component in creating new and effective drugs to combat various diseases.
Used in Organic Chemistry:
In the field of organic chemistry, 1-(2,6-dichlorobenzyl)-5-oxo-L-proline is used as an intermediate in the production of various compounds with biological activity. Its versatility allows for its incorporation into a wide range of chemical reactions, leading to the creation of novel compounds with potential applications in various industries.
Used in Antiviral and Antibacterial Applications:
1-(2,6-dichlorobenzyl)-5-oxo-L-proline is also being studied for its potential therapeutic applications, particularly in the field of antiviral and antibacterial medications. Its ability to be incorporated into pharmaceutical compounds makes it a promising candidate for the development of new treatments against viral and bacterial infections.
Overall, 1-(2,6-dichlorobenzyl)-5-oxo-L-proline is a valuable chemical compound with a wide range of applications in the pharmaceutical and organic chemistry industries, as well as potential therapeutic uses in antiviral and antibacterial medications.

Check Digit Verification of cas no

The CAS Registry Mumber 59749-37-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,7,4 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 59749-37:
(7*5)+(6*9)+(5*7)+(4*4)+(3*9)+(2*3)+(1*7)=180
180 % 10 = 0
So 59749-37-0 is a valid CAS Registry Number.

59749-37-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-1-[(2,6-dichlorophenyl)methyl]-5-oxopyrrolidine-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59749-37-0 SDS

59749-37-0Relevant articles and documents

Synthesis and identification of chiral aminomethylpiperidine carboxamides as inhibitor of collagen induced platelet activation

Anil Kumar,Misra, Ankita,Siddiqi, Tanveer Irshad,Srivastava, Stuti,Jain, Manish,Bhatta, Rabi Sankar,Barthwal, Manoj,Dikshit, Madhu,Dikshit, Dinesh K.

, p. 456 - 472 (2014/06/09)

A series of chiral lactam carboxamides of aminomethylpiperidine were synthesized and investigated for the collagen induced in vitro anti-platelet efficacy and collagen plus epinephrine induced in vivo pulmonary thromboembolism. The compound 31a (30 μM/kg) displayed a remarkable antithrombotic efficacy (60% protection) which was sustained for more than 24 h and points to its excellent bioavailability. The compounds 31a (IC50 = 6.6 μM) and 32a (IC50 = 37 μM), as well as their racemic mixture 28i (IC50 = 16 μM) significantly inhibited collagen-induced human platelet aggregation in vitro. Compound 34c displayed dual mechanism of action against both collagen (IC50 = 3.3 μM) and U46619 (IC50 = 2.7 μM) induced platelet aggregation. The pharmacokinetic study of 31a indicated very faster absorption, prolonged and constant systemic exposure and thereby exhibiting better therapeutic response.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 59749-37-0